ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $234,000 | -65.5% | 21,570 | -67.3% | 0.00% | -100.0% |
| Q3 2020 | $679,000 | -63.6% | 65,878 | -26.2% | 0.00% | -66.7% |
| Q2 2020 | $1,865,000 | +7.6% | 89,320 | -49.7% | 0.00% | 0.0% |
| Q1 2020 | $1,733,000 | +289.4% | 177,428 | +358.9% | 0.00% | +200.0% |
| Q4 2019 | $445,000 | +179.9% | 38,666 | +32.8% | 0.00% | – |
| Q3 2019 | $159,000 | -44.8% | 29,119 | +20.0% | 0.00% | – |
| Q2 2019 | $288,000 | +59.1% | 24,261 | -29.9% | 0.00% | – |
| Q1 2019 | $181,000 | -25.8% | 34,591 | -55.3% | 0.00% | – |
| Q4 2018 | $244,000 | -71.0% | 77,386 | -44.4% | 0.00% | -100.0% |
| Q3 2018 | $841,000 | +357.1% | 139,078 | +300.0% | 0.00% | – |
| Q2 2018 | $184,000 | -53.1% | 34,772 | -71.9% | 0.00% | -100.0% |
| Q2 2016 | $392,000 | – | 123,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
| Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
| ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
| RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
| Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
| VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
| Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
| VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
| Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |